Generic drugmakers may file ANDA (Abbreviated New Drug Application) lawsuits under the Hatch-Waxman Act, claiming that some of Novo Nordisks patents are invalid or not infringed
Additional Phase 3 trials are still underway, including TRIUMPH-2 (evaluating retatrutide in adults with obesity and type 2 diabetes) and TRIUMPH-3 (evaluating cardiovascular outcomes), with results expected later in 2026
And universal screening would generate far more harm through false positives than benefit through early detection of an already rare cancer
Answer: Glutathione injections deliver a concentrated dose of glutathione, the body's master antioxidant, directly into muscle or a vein, bypassing the digestive system where oral glutathione breaks down before it can be absorbed
NAD+ is simply an oxidized form of NAD that can be readily used by the body
J., Barrett-O'Keefe, Z., and Richardson, R